Your browser doesn't support javascript.
Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan - Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease.
Ishii, Hideki; Amano, Tetsuya; Yamaji, Kyohei; Kohsaka, Shun; Yokoi, Hiroyoshi; Ikari, Yuji.
  • Ishii H; Department of Cardiology, Fujita Health University Bantane Hospital.
  • Amano T; Department of Cardiology, Aichi Medical University.
  • Yamaji K; Division of Cardiology, Kokura Memorial Hospital.
  • Kohsaka S; Department of Cardiology, Keio University.
  • Yokoi H; Cardiovascular Center, Fukuoka Sanno Hospital.
  • Ikari Y; Department of Cardiology, Tokai University.
Circ J ; 84(12): 2185-2189, 2020 11 25.
Article in English | MEDLINE | ID: covidwho-788838
ABSTRACT

BACKGROUND:

With the rapid spread of COVID-19, hospitals providing percutaneous coronary intervention (PCI) were placed in unique and unfamiliar circumstances. This study evaluated variations in the treatment of coronary artery disease according to time course of the COVID-19 pandemic in Japan.Methods and 

Results:

The Japanese Association of Cardiovascular Intervention and Therapeutics performed serial surveys during the pandemic (in mid-April, late-April and mid-May 2020) with queries regarding the implementation of PCI. Hospitals were asked about their treatment strategies for elective PCI and emergency PCI for ST-elevation myocardial infarction (STEMI) and high-risk acute coronary syndrome (ACS) patients. Most hospitals opted to perform primary PCI in the usual manner at the beginning of the pandemic. As the pandemic progressed, hospitals in the 7 populated areas downgraded the performance of PCI for chronic coronary syndrome and high-risk ACS, but not for STEMI patients. After the state of emergency was lifted in most prefectures in mid-May, the rate of PCI gradually normalized. Screening tests, such as polymerase chain reaction and chest computed tomography, in ACS were frequently used.

CONCLUSIONS:

The COVID-19 pandemic greatly affected PCI treatment in Japan. However, even in the most critical situations during the pandemic, most institutions continued to perform primary PCI normally for STEMI patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Outcome and Process Assessment, Health Care / Coronary Artery Disease / Acute Coronary Syndrome / Pandemics / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Circ J Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Outcome and Process Assessment, Health Care / Coronary Artery Disease / Acute Coronary Syndrome / Pandemics / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Circ J Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article